Pathogenesis of the hyperlipidemia of Gram-negative bacterial sepsis may involve pathomorphological changes in liver sinusoidal endothelial cells

International Journal of Infectious Diseases

Volumn 14, Issue 10, 2010, Pages

  Cheluvappa, Rajkumar ^a   Denning, Gerene M ^b   Lau, Gee W ^c   Grimm, Michael C ^a   Hilmer, Sarah N ^d,e   Le Couteur, David G ^d  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^d Department of Microbiology and Infectious Diseases   (Australia)

^e ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Electron microscopy; Immunohistochemistry; Liver sinusoidal endothelial cell fenestrations; Oxidative stress; Pseudomonas aeruginosa Pyocyanin; Transplantation

Indexed keywords

LIPOPOLYSACCHARIDE; LIPOPROTEIN LIPASE; PYOCYANINE; TRIACYLGLYCEROL;

CELL INTERACTION; CELL LOSS; CELL STRUCTURE; CYTOSKELETON; ENZYME INHIBITION; GRAM NEGATIVE INFECTION; HUMAN; HYPERLIPIDEMIA; IMMUNOLOGICAL TOLERANCE; LIVER CELL; LIVER SINUSOID; NONHUMAN; PATHOGENESIS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; REVIEW;

BACTERIAL TOXINS; HUMANS; HYPERLIPIDEMIAS; LIVER; LIVER CIRCULATION; LIVER DISEASES; LIVER TRANSPLANTATION; OPPORTUNISTIC INFECTIONS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SEPSIS;

EID: 77957756211     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2010.02.2263     Document Type: Review

References (187)

1. Soave R., Murray H.W., Litrenta M.M. Bacterial invasion of pulmonary vessels. Pseudomonas bacteremia mimicking pulmonary thromboembolism with infarction. Am J Med 1978, 65:864-867.
2. Schaber J.A., Triffo W.J., Suh S.J., Oliver J.W., Hastert M.C., Griswold J.A., et al. Pseudomonas aeruginosa forms biofilms in acute infection independent of cell-to-cell signaling. Infect Immun 2007, 75:3715-3721.
3. Fetzer A.E., Werner A.S., Hagstrom J.W. Pathologic features of pseudomonal pneumonia. Am Rev Respir Dis 1967, 96:1121-1130.
4. Takahashi K., Sawasaki Y., Hata J., Mukai K., Goto T. Spontaneous transformation and immortalization of human endothelial cells. In Vitro Cell Dev Biol 1990, 26:265-274.
5. Valente E., Assis M.C., Alvim I.M., Pereira G.M., Plotkowski M.C. Pseudomonas aeruginosa induces apoptosis in human endothelial cells. Microb Pathog 2000, 29:345-356.
6. Britigan B.E., Rasmussen G.T., Cox C.D. Augmentation of oxidant injury to human pulmonary epithelial cells by the Pseudomonas aeruginosa siderophore pyochelin. Infect Immun 1997, 65:1071-1076.
7. Hassan H.M., Fridovich I. Mechanism of the antibiotic action of pyocyanine. J Bacteriol 1980, 141:156-163.
8. Muller M. Pyocyanin induces oxidative stress in human endothelial cells and modulates the glutathione redox cycle. Free Rad Biol Med 2002, 33:1527-1533.
9. Muhlradt P.F., Tsai H., Conradt P. Effects of pyocyanine, a blue pigment from Pseudomonas aeruginosa, on separate steps of T cell activation: interleukin 2 (IL 2) production, IL 2 receptor formation, proliferation and induction of cytolytic activity. Eur J Immunol 1986, 16:434-440.
10. Muller P.K., Krohn K., Muhlradt P.F. Effects of pyocyanine, a phenazine dye from Pseudomonas aeruginosa, on oxidative burst and bacterial killing in human neutrophils. Infect Immun 1989, 57:2591-2596.
11. Lau G.W., Ran H., Kong F., Hassett D.J., Mavrodi D. Pseudomonas aeruginosa pyocyanin is critical for lung infection in mice. Infect Immun 2004, 72:4275-4278.
12. Harman J.W., Macbrinn M.C. The effect of phenazine methosulphate, pyocyanine and EDTA on mitochondrial succinic dehydrogenase. Biochem Pharmacol 1963, 12:1265-1278.
13. Usher L.R., Lawson R.A., Geary I., Taylor C.J., Bingle C.D., Taylor G.W., Whyte M.K. Induction of neutrophil apoptosis by the Pseudomonas aeruginosa exotoxin pyocyanin: a potential mechanism of persistent infection. J Immunol 2002, 168:1861-1868.
14. Muller M. Premature cellular senescence induced by pyocyanin, a redox-active Pseudomonas aeruginosa toxin. Free Radic Biol Med 2006, 41:1670-1677.
15. Britigan B.E., Roeder T.L., Rasmussen G.T., Shasby D.M., McCormick M.L., Cox C.D. Interaction of the Pseudomonas aeruginosa secretory products pyocyanin and pyochelin generates hydroxyl radical and causes synergistic damage to endothelial cells. Implications for Pseudomonas-associated tissue injury. J Clin Invest 1992, 90:2187-2196.
16. Cheluvappa R., Jamieson H.A., Hilmer S.N., Muller M., Le Couteur D.G. The effect of Pseudomonas aeruginosa virulence factor, pyocyanin, on the liver sinusoidal endothelial cell. J Gastroenterol Hepatol 2007, 22:1350-1351.
17. Cogger V.C., Mross P.E., Hosie M.J., Ansselin A.D., McLean A.J., Le Couteur D.G. The effect of acute oxidative stress on the ultrastructure of the perfused rat liver. Pharmacol Toxicol 2001, 89:306-311.
18. Dobbs B.R., Rogers G.W., Xing H.Y., Fraser R. Endotoxin-induced defenestration of the hepatic sinusoidal endothelium: a factor in the pathogenesis of cirrhosis?. Liver 1994, 14:230-233.
19. Seto S., Kaido T., Yamaoka S., Yoshikawa A., Arii S., Nakamura T., et al. Hepatocyte growth factor prevents lipopolysaccharide-induced hepatic sinusoidal endothelial cell injury and intrasinusoidal fibrin deposition in rats. J Surg Res 1998, 80:194-199.
20. Cheluvappa R., Cogger V.C., Kwun S.Y., O'Reilly J.N., Le Couteur D.G., Hilmer S.N. Liver sinusoidal endothelial cells and acute non-oxidative hepatic injury induced by Pseudomonas aeruginosa pyocyanin. Int J Exp Pathol 2008, 89:410-418.
21. Sumitran-Holgersson S., Ge X., Karrar A., Xu B., Nava S., Broome U., et al. A novel mechanism of liver allograft rejection facilitated by antibodies to liver sinusoidal endothelial cells. Hepatology 2004, 40:1211-1221.
22. Fraser R., Dobbs B.R., Rogers G.W. Lipoproteins and the liver sieve: the role of the fenestrated sinusoidal endothelium in lipoprotein metabolism, atherosclerosis, and cirrhosis. Hepatology 1995, 21:863-874.
23. Le Couteur D.G., Fraser R., Hilmer S., Rivory L.P., McLean A.J. The hepatic sinusoid in aging and cirrhosis: effects on hepatic substrate disposition and drug clearance. Clin Pharmacokinet 2005, 44:187-200.
24. Wisse E., Braet F., Luo D., De Zanger R., Jans D., Crabbe E., Vermoesen A. Structure and function of sinusoidal lining cells in the liver. Toxicol Pathol 1996, 24:100-111.
25. Wake K., Decker K., Kirn A., Knook D.L., McCuskey R.S., Bouwens L., Wisse E. Cell biology and kinetics of Kupffer cells in the liver. Int Rev Cytol 1989, 118:173-229.
26. Bouwens L. Structural and functional aspects of Kupffer cells. Revis Biol Celular 1988, 16:69-94.
27. Kmiec Z. Cooperation of liver cells in health and disease. Adv Anat Embryol Cell Biol 2001, 161(III-XIII):1-151.
28. Bouwens L., De Bleser P., Vanderkerken K., Geerts B., Wisse E. Liver cell heterogeneity: functions of non-parenchymal cells. Enzyme 1992, 46:155-168.
29. Wisse W., De Zanger R.B., Charels K., Van Der Smissen P., McCuskey R.S. The liver sieve: considerations concerning the structure and function of endothelial fenestrae, the sinusoidal wall and the space of Disse. Hepatology 1985, 5:683-692.
30. Henriksen J.H., Horn T., Christoffersen P. The blood-lymph barrier in the liver. A review based on morphological and functional concepts of normal and cirrhotic liver. Liver 1984, 4:221-232.
31. Braet F., De Zanger R., Crabbe E., Wisse E. New observations on cytoskeleton and fenestrae in isolated rat liver sinusoidal endothelial cells. J Gastroenterol Hepatol 1995, 10(Suppl 1):S3-7.
32. Fraser R., Rogers G.W.T., Sutton L.E., Dobbs B.R. Single dose models of defenestration: tools to explore mechanisms, modulation and measurement of hepatic sinusoidal porosity. Cells of the hepatic sinusoid 1995, vol. 5:263-266. Kupffer Cell Foundation, Leiden.
33. Wisse E. An electron microscopic study of the fenestrated endothelial lining of rat liver sinusoids. J Ultrastruct Res 1970, 31:125-150.
34. Wisse E., De Zanger R.B., Jacobs R., McCuskey R.S. Scanning electron microscope observations on the structure of portal veins, sinusoids and central veins in rat liver. Scan Electron Microsc 1983, (Pt 3):1441-1452.
35. Horn T., Henriksen J.H., Christoffersen P. The sinusoidal lining cells in 'normal' human liver. A scanning electron microscopic investigation. Liver 1986, 6:98-110.
36. Vidal-Vanaclocha F., Barbera-Guillem E. Fenestration patterns in endothelial cells of rat liver sinusoids. J Ultrastruct Res 1985, 90:115-123.
37. Steffan A.M., Gendrault J.L., Kirn A. Increase in the number of fenestrae in mouse endothelial liver cells by altering the cytoskeleton with cytochalasin B. Hepatology 1987, 7:1230-1238.
38. Braet F., De Zanger R., Baekeland M., Crabbe E., Van Der Smissen P., Wisse E. Structure and dynamics of the fenestrae-associated cytoskeleton of rat liver sinusoidal endothelial cells. Hepatology 1995, 21:180-189.
39. Oda M., Kazemoto S., Kaneko H., Yokomori H., Ishii K., Tsukada N., et al. Involvement of Ca++-calmodulin-actomyosin system in contractility of hepatic sinusoidal endothelial fenestrae. Cells of the hepatic sinusoid 1993, Vol. 4:174-178. Kupffer Cell Foundation, Leiden.
40. Tsukada N., Oda M., Yonei M. Alterations of the hepatic sinusoidal fenestrae in response to vasoactive substances in the rat-in vivo and in vitro studies. Cells of the hepatic sinusoid 1986, Vol. 1:515-516. Kupffer Cell Foundation, Rijswijk.
41. Wisse E., De Zanger R., Fraser R., McCuskey R.S. On the role of liver endothelial filter in the transport of particulate fat (chylomicrons and their remnants) to parenchymal cells and the influence of certain hormones on the endothelial fenestrae. Communications of liver cells 1980, MTP Press, Lancaster, pp. 195-200. H. Popper (Ed.).
42. Gatmaitan Z., Varticovski L., Ling L., Mikkelsen R., Steffan A.M., Arias I.M. Studies on fenestral contraction in rat liver endothelial cells in culture. Am J Pathol 1996, 148:2027-2041.
43. Braet F., Muller M., Vekemans K., Wisse E., Le Couteur D.G. Antimycin A-induced defenestration in rat hepatic sinusoidal endothelial cells. Hepatology 2003, 38:394-402.
44. Ogino J., Yamada T., Goto R., Kikushima K., Fujimori I. [Growth inhibitory activity of clinical isolates of Pseudomonas aeruginosa against Staphylococcus aureus (MRSA and MSSA)]. Kansenshogaku Zasshi 1992, 66:909-913.
45. Charels K., De Zanger R.B., Van Bossuyt H., Van Der Smissen P., Wisse W. Influence of acute alcohol administration on endothelial fenestrae of rat livers. Cells of the hepatic sinusoid 1986, Vol. 1:497-502. Kupffer Cell Foundation, Rijswijk.
46. Mori T., Okanoue T., Sawa Y., Itoh Y., Kanaoka H., Hori N., Enjyo F., Nakagawa Y., Kagawa K., Kashima K Effect of ethanol on the sinusoidal endothelial fenestrations of rat liver - in vivo an in vitro study. Cells of the Hepatic Sinusoid 1991, vol. 3. Kupffer Cell Foundation, Leiden, pp. 469-471.
47. Fraser R., Bowler L.M., Day W.A. Damage of rat liver sinusoidal endothelium by ethanol. Pathology 1980, 12:371-376.
48. Sarphie G., D'Souza N.B., Van Thiel D.H., Hill D., McClain C.J., Deaciuc I.V. Dose- and time-dependent effects of ethanol on functional and structural aspects of the liver sinusoid in the mouse. Alcohol Clin Exp Res 1997, 21:1128-1136.
49. Horn T., Christoffersen P., Henriksen J.H. Alcoholic liver injury: defenestration in noncirrhotic livers-a scanning electron microscopic study. Hepatology 1987, 7:77-82.
50. Clark S.A., Angus H.B., Cook H.B., George P.M., Oxner R.B., Fraser R. Defenestration of hepatic sinusoids as a cause of hyperlipoproteinaemia in alcoholics. Lancet 1988, 2:1225-1227.
51. Nopanitaya W., Grisham J.W., Carson J.L., Dotson M.M. Surface features of cirrhotic liver. Virchows Arch A Pathol Anat Histol 1976, 372:97-108.
52. Fraser R., Clark S.A., Day W.A., Murray F.E. Nicotine decreases the porosity of the rat liver sieve: a possible mechanism for hypercholesterolaemia. Br J Exp Pathol 1988, 69:345-350.
53. Cogger V.C., Hilmer S.N., Sullivan D., Muller M., Fraser R., Le Couteur D.G. Hyperlipidemia and surfactants: the liver sieve is a link. Atherosclerosis 2006, 189:273-281.
54. Le Couteur D.G., Fraser R., Cogger V.C., McLean A.J. Hepatic pseudocapillarisation and atherosclerosis in ageing. Lancet 2002, 359:1612-1615.
55. Walker R.M., Racz W.J., McElligott T.F. Scanning electron microscopic examination of acetaminophen-induced hepatotoxicity and congestion in mice. Am J Pathol 1983, 113:321-330.
56. Nopanitaya W., Lamb J.C., Grisham J.W., Carson J.L. Effect of hepatic venous outflow obstruction on pores and fenestration in sinusoidal endothelium. Br J Exp Pathol 1976, 57:604-609.
57. Fraser R., Bowler L.M., Day W.A., Dobbs B., Johnson H.D., Lee D. High perfusion pressure damages the sieving ability of sinusoidal endothelium in rat livers. Br J Exp Pathol 1980, 61:222-228.
58. Jamieson H.A., Cogger V.C., Twigg S.M., McLennan S.V., Warren A., Cheluvappa R., et al. Alterations in liver sinusoidal endothelium in a baboon model of type 1 diabetes. Diabetologia 2007, 50:1969-1976.
59. Singleton J.R., Smith A.G., Russell J.W., Feldman E.L. Microvascular complications of impaired glucose tolerance. Diabetes 2003, 52:2867-2873.
60. Le Couteur D.G., Cogger V.C., Markus A.M., Harvey P.J., Yin Z.L., Ansselin A.D., McLean A.J. Pseudocapillarization and associated energy limitation in the aged rat liver. Hepatology 2001, 33:537-543.
61. Cogger V.C., Warren A., Fraser R., Ngu M., McLean A.J., Le Couteur D.G. Hepatic sinusoidal pseudocapillarization with aging in the non-human primate. Exp Gerontol 2003, 38:1101-1107.
62. McLean A.J., Cogger V.C., Chong G.C., Warren A., Markus A.M., Dahlstrom J.E., Le Couteur D.G. Age-related pseudocapillarization of the human liver. J Pathol 2003, 200:112-117.
63. Warren A., Bertolino P., Cogger V.C., McLean A.J., Fraser R., Couteur D.G. Hepatic pseudocapillarization in aged mice. Exp Gerontol 2005, 40:807-812.
64. Hilmer S.N., Cogger V.C., Fraser R., McLean A.J., Sullivan D., Le Couteur D.G. Age-related changes in the hepatic sinusoidal endothelium impede lipoprotein transfer in the rat. Hepatology 2005, 42:1349-1354.
65. Mamo J.C., Elsegood C.L., Umeda Y., Hirano T., Redgrave T.G. Effect of probucol on plasma clearance and organ uptake of chylomicrons and VLDLs in normal and diabetic rats. Arterioscler Thromb 1993, 13:231-239.
66. Battula S.B., Fitzsimons O., Moreno S., Owens D., Collins P., Johnson A., Tomkin G.H. Postprandial apolipoprotein B48- and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism?. Metabolism 2000, 49:1049-1054.
67. Adiels M., Olofsson S.O., Taskinen M.R., Boren J. Diabetic dyslipidaemia. Curr Opin Lipidol 2006, 17:238-246.
68. Naito M., Wisse E. Filtration effect of endothelial fenestrations on chylomicron transport in neonatal rat liver sinusoids. Cell Tissue Res 1978, 190:371-382.
69. Fraser R., Bosanquet A.G., Day W.A. Filtration of chylomicrons by the liver may influence cholesterol metabolism and atherosclerosis. Atherosclerosis 1978, 29:113-123.
70. Enomoto N., Ikejima K., Bradford B.U., Rivera C.A., Kono H., Goto M., et al. Role of Kupffer cells and gut-derived endotoxins in alcoholic liver injury. J Gastroenterol Hepatol 2000, 15(Suppl):D20-D25.
71. Knolle P.A., Gerken G. Local control of the immune response in the liver. Immunol Rev 2000, 174:21-34.
72. Jacob A.I., Goldberg P.K., Bloom N., Degenshein G.A., Kozinn P.J. Endotoxin and bacteria in portal blood. Gastroenterology 1977, 72:1268-1270.
73. Ueno M. [Endotoxemia and its compensatory mechanisms in experimental liver cirrhosis]. Nippon Shokakibyo Gakkai Zasshi 1990, 87:1692-1700.
74. Knolle P.A., Germann T., Treichel U., Uhrig A., Schmitt E., Hegenbarth S., et al. Endotoxin down-regulates T cell activation by antigen-presenting liver sinusoidal endothelial cells. J Immunol 1999, 162:1401-1407.
75. Warren A., Le Couteur D.G., Fraser R., Bowen D.G., McCaughan G.W., Bertolino P. T lymphocytes interact with hepatocytes through fenestrations in murine liver sinusoidal endothelial cells. Hepatology 2006, 44:1182-1190.
76. Warren A., Bertolino P., Benseler V., Fraser R., McCaughan G.W., Le Couteur D.G. Marked changes of the hepatic sinusoid in a transgenic mouse model of acute immune-mediated hepatitis. J Hepatol 2007, 46:239-246.
77. Schumann J., Wolf D., Pahl A., Brune K., Papadopoulos T., van Rooijen N., Tiegs G. Importance of Kupffer cells for T-cell-dependent liver injury in mice. Am J Pathol 2000, 157:1671-1683.
78. Schumann J., Bluethmann H., Tiegs G. Synergism of Pseudomonas aeruginosa exotoxin A with endotoxin, superantigen, or TNF results in TNFR1- and TNFR2-dependent liver toxicity in mice. Immunol Lett 2000, 74:165-172.
79. Gorgen I., Hartung T., Leist M., Niehorster M., Tiegs G., Uhlig S., et al. Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-alpha. J Immunol 1992, 149:918-924.
80. Jaeschke H., Farhood A., Fisher M.A., Smith C.W. Sequestration of neutrophils in the hepatic vasculature during endotoxemia is independent of beta 2 integrins and intercellular adhesion molecule-1. Shock 1996, 6:351-356.
81. Jaeschke H., Farhood A. Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver. Am J Physiol 1991, 260:G355-G362.
82. Jaeschke H. Neutrophil-mediated tissue injury in alcoholic hepatitis. Alcohol 2002, 27:23-27.
83. Jaeschke H., Gores G.J., Cederbaum A.I., Hinson J.A., Pessayre D., Lemasters J.J. Mechanisms of hepatotoxicity. Toxicol Sci 2002, 65:166-176.
84. Enomoto N., Schemmer P., Ikejima K., Takei Y., Sato N., Brenner D.A., Thurman R.G. Long-term alcohol exposure changes sensitivity of rat Kupffer cells to lipopolysaccharide. Alcohol Clin Exp Res 2001, 25:1360-1367.
85. Tiegs G., Wendel A. Leukotriene-mediated liver injury. Biochem Pharmacol 1988, 37:2569-2573.
86. Tiegs G., Wolter M., Wendel A. Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice. Biochem Pharmacol 1989, 38:627-631.
87. Spolarics Z., Stein D.S., Garcia Z.C. Endotoxin stimulates hydrogen peroxide detoxifying activity in rat hepatic endothelial cells. Hepatology 1996, 24:691-696.
88. Jaeschke H. Enhanced sinusoidal glutathione efflux during endotoxin-induced oxidant stress in vivo. Am J Physiol 1992, 263:G60-G68.
89. Spolarics Z., Navarro L. Endotoxin stimulates the expression of glucose-6-phosphate dehydrogenase in Kupffer and hepatic endothelial cells. J Leukoc Biol 1994, 56:453-457.
90. Spolarics Z. Endotoxemia, pentose cycle, and the oxidant/antioxidant balance in the hepatic sinusoid. J Leuk Biol 1998, 63:534-541.
91. Yokoyama H., Mizukami T., Kamegaya Y., Fukuda M., Okamura Y., Matsumoto M., et al. Formation of superoxide anion in the hepatic sinusoid after lipopolysaccharide challenge. Alcohol Clin Exp Res 1998, 22:133S-136S.
92. Luyendyk J.P., Maddox J.F., Green C.D., Ganey P.E., Roth R.A. Role of hepatic fibrin in idiosyncrasy-like liver injury from lipopolysaccharide-ranitidine coexposure in rats. Hepatology 2004, 40:1342-1351.
93. Luyendyk J.P., Mattes W.B., Burgoon L.D., Zacharewski T.R., Maddox J.F., Cosma G.N., et al. Gene expression analysis points to hemostasis in livers of rats cotreated with lipopolysaccharide and ranitidine. Toxicol Sci 2004, 80:203-213.
94. Copple B.L., Moulin F., Hanumegowda U.M., Ganey P.E., Roth R.A. Thrombin and protease-activated receptor-1 agonists promote lipopolysaccharide-induced hepatocellular injury in perfused livers. J Pharmacol Exp Ther 2003, 305:417-425.
95. Moulin F., Pearson J.M., Schultze A.E., Scott M.A., Schwartz K.A., Davis J.M., et al. Thrombin is a distal mediator of lipopolysaccharide-induced liver injury in the rat. J Surg Res 1996, 65:149-158.
96. Kume M., Hayashi T., Yuasa H., Tanaka H., Nishioka J., Ido M., et al. Bacterial lipopolysaccharide decreases thrombomodulin expression in the sinusoidal endothelial cells of rats-a possible mechanism of intrasinusoidal microthrombus formation and liver dysfunction. J Hepatol 2003, 38:9-17.
97. Pearson J.M., Schultze A.E., Jean P.A., Roth R.A. Platelet participation in liver injury from Gram-negative bacterial lipopolysaccharide in the rat. Shock 1995, 4:178-186.
98. Hewett J.A., Roth R.A. The coagulation system, but not circulating fibrinogen, contributes to liver injury in rats exposed to lipopolysaccharide from Gram-negative bacteria. J Pharmacol Exp Ther 1995, 272:53-62.
99. Takeuchi M., Nakashima Y., Miura Y., Nakagawa K., Uragoh K., Iwanaga S., et al. The localization of lipopolysaccharide in an endotoxemic rat liver and its relation to sinusoidal thrombogenesis: light and electron microscopic studies. Pathol Res Pract 1994, 190:1123-1133.
100. Salgia R., Becker J.H., Sayeed M.M. Altered membrane fluidity in rat hepatocytes during endotoxic shock. Mol Cell Biochem 1993, 121:143-148.
101. Ogle C.K., Guo X., Wu J.Z., Ogle J.D., Fischer J.E. Effect of hepatocytes from normal or endotoxin treated animals on the production of tumour necrosis factor, interleukin-6, and prostaglandin-E2 by macrophages incubated in vitro with various fatty acids. Eur J Surg 1995, 161:123-127.
102. Lang C.H., Pollard V., Fan J., Traber L.D., Traber D.L., Frost R.A., et al. Acute alterations in growth hormone-insulin-like growth factor axis in humans injected with endotoxin. Am J Physiol 1997, 273:R371-R378.
103. Gaeta G.B., Wisse E. Endotoxin effect on the isolated perfused rat liver: functional and ultrastructural observations. J Submicrosc Cytol 1983, 15:705-712.
104. Jia J.B., Han D.W., Xu R.L., Gao F., Zhao L.F., Zhao Y.C., et al. Effect of endotoxin on fibronectin synthesis of rat primary cultured hepatocytes. World J Gastroenterol 1998, 4:329-331.
105. Yee S.B., Ganey P.E., Roth R.A. The role of Kupffer cells and TNF-alpha in monocrotaline and bacterial lipopolysaccharide-induced liver injury. Toxicol Sci 2003, 71:124-132.
106. Luyendyk J.P., Copple B.L., Barton C.C., Ganey P.E., Roth R.A. Augmentation of aflatoxin B1 hepatotoxicity by endotoxin: involvement of endothelium and the coagulation system. Toxicol Sci 2003, 72:171-181.
107. Brown A.P., Schultze A.E., Holdan W.L., Buchweitz J.P., Roth R.A., Ganey P.E. Lipopolysaccharide-induced hepatic injury is enhanced by polychlorinated biphenyls. Environ Health Perspect 1996, 104:634-640.
108. Roth R.A., Harkema J.R., Pestka J.P., Ganey P.E. Is exposure to bacterial endotoxin a determinant of susceptibility to intoxication from xenobiotic agents?. Toxicol Appl Pharmacol 1997, 147:300-311.
109. Scoazec J.Y., Feldmann G. In situ immunophenotyping study of endothelial cells of the human hepatic sinusoid: results and functional implications. Hepatology 1991, 14:789-797.
110. Knolle P.A., Schmitt E., Jin S., Germann T., Duchmann R., Hegenbarth S., et al. Induction of cytokine production in naive CD4(+) T cells by antigen-presenting murine liver sinusoidal endothelial cells but failure to induce differentiation toward Th1 cells. Gastroenterology 1999, 116:1428-1440.
111. Knolle P.A., Uhrig A., Hegenbarth S., Loser E., Schmitt E., Gerken G., Lohse A.W. IL-10 down-regulates T cell activation by antigen-presenting liver sinusoidal endothelial cells through decreased antigen uptake via the mannose receptor and lowered surface expression of accessory molecules. Clin Exp Immunol 1998, 114:427-433.
112. Magnusson S., Berg T. Extremely rapid endocytosis mediated by the mannose receptor of sinusoidal endothelial rat liver cells. Biochem J 1989, 257:651-656.
113. Scoazec J.Y., Feldmann G. Both macrophages and endothelial cells of the human hepatic sinusoid express the CD4 molecule, a receptor for the human immunodeficiency virus. Hepatology 1990, 12:505-510.
114. Lohse A.W., Knolle P.A., Bilo K., Uhrig A., Waldmann C., Ibe M., et al. Antigen-presenting function and B7 expression of murine sinusoidal endothelial cells and Kupffer cells. Gastroenterology 1996, 110:1175-1181.
115. Knolle P.A., Limmer A. Control of immune responses by scavenger liver endothelial cells. Swiss Med Wkly 2003, 133:501-506.
116. Klugewitz K., Blumenthal-Barby F., Schrage A., Knolle P.A., Hamann A., Crispe I.N. Immunomodulatory effects of the liver: deletion of activated CD4+ effector cells and suppression of IFN-gamma-producing cells after intravenous protein immunization. J Immunol 2002, 169:2407-2413.
117. Limmer A., Knolle P.A. Liver sinusoidal endothelial cells: a new type of organ-resident antigen-presenting cell. Arch Immunol Ther Exp (Warsz) 2001, 49(Suppl 1):S7-11.
118. Limmer A., Ohl J., Wingender G., Berg M., Jungerkes F., Schumak B., et al. Cross-presentation of oral antigens by liver sinusoidal endothelial cells leads to CD8 T cell tolerance. Eur J Immunol 2005, 35:2970-2981.
119. Shnyra A., Hultenby K., Lindberg A.A. Role of the physical state of Salmonella lipopolysaccharide in expression of biological and endotoxic properties. Infect Immun 1993, 61:5351-5360.
120. Shnyra A., Lindberg A.A. Scavenger receptor pathway for lipopolysaccharide binding to Kupffer and endothelial liver cells in vitro. Infect Immun 1995, 63:865-873.
121. Smedsrod B., Pertoft H., Gustafson S., Laurent T.C. Scavenger functions of the liver endothelial cell. Biochem J 1990, 266:313-327.
122. Svistounov D., Smedsrod B. Hepatic clearance of advanced glycation end products (AGEs)-myth or truth?. J Hepatol 2004, 41:1038-1040.
123. Gong J.P., Dai L.L., Liu C.A., Wu C.X., Shi Y.J., Li S.W., Li X.H. Expression of CD14 protein and its gene in liver sinusoidal endothelial cells during endotoxemia. World J Gastroenterol 2002, 8:551-554.
124. Gouvea E.F., Branco R.C., Monteiro R.C., Halpern M., Ribeiro-Filho J., Silveira V.G., et al. Outcome of infections caused by multiple drug-resistant bacteria in liver transplant recipients. Transplant Proc 2004, 36:958-960.
125. Iinuma Y., Senda K., Fujihara N., Saito T., Takakura S., Kudo T., et al. Surgical site infection in living-donor liver transplant recipients: a prospective study. Transplantation 2004, 78:704-709.
126. Singh N., Wagener M.M., Obman A., Cacciarelli T.V., de Vera M.E., Gayowski T. Bacteremias in liver transplant recipients: shift toward Gram-negative bacteria as predominant pathogens. Liver Transpl 2004, 10:844-849.
127. Hart D.W., Gore D.C., Rinehart A.J., Asimakis G.K., Chinkes D.L. Sepsis-induced failure of hepatic energy metabolism. J Surg Res 2003, 115:139-147.
128. Hart D.W., Chinkes D.L., Gore D.C. Increased tissue oxygen extraction and acidosis with progressive severity of sepsis. J Surg Res 2003, 112:49-58.
129. Muhlen K.A., Schumann J., Wittke F., Stenger S., Van Rooijen N., Van Kaer L., Tiegs G. NK cells, but not NKT cells, are involved in Pseudomonas aeruginosa exotoxin A-induced hepatotoxicity in mice. J Immunol 2004, 172:3034-3041.
130. Schumann J., Muhlen K., Kiemer A.K., Vollmar A.M., Tiegs G. Parenchymal, but not leukocyte, TNF receptor 2 mediates T cell-dependent hepatitis in mice. J Immunol 2003, 170:2129-2137.
131. Pitt T.L. Biology of Pseudomonas aeruginosa in relation to pulmonary infection in cystic fibrosis. J R Soc Med 1986, 79(Suppl 12):13-18.
132. Wilson R., Pitt T., Taylor G., Watson D., MacDermot J., Sykes D., et al. Pyocyanin and 1-hydroxyphenazine produced by Pseudomonas aeruginosa inhibit the beating of human respiratory cilia in vitro. J Clin Invest 1987, 79:221-229.
133. Wilson R., Sykes D.A., Watson D., Rutman A., Taylor G.W., Cole P.J. Measurement of Pseudomonas aeruginosa phenazine pigments in sputum and assessment of their contribution to sputum sol toxicity for respiratory epithelium. Infect Immun 1988, 56:2515-2517.
134. O'Malley Y.Q., Reszka K.J., Spitz D.R., Denning G.M., Britigan B.E. Pseudomonas aeruginosa pyocyanin directly oxidizes glutathione and decreases its levels in airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 2004, 287:L94-103.
135. Schumann J., Angermuller S., Bang R., Lohoff M., Tiegs G. Acute hepatotoxicity of Pseudomonas aeruginosa exotoxin A in mice depends on T cells and TNF. J Immunol 1998, 161:5745-5754.
136. Takei Y., Kawano S., Nishimura Y., Goto M., Nagai H., Chen S.S., et al. Apoptosis: a new mechanism of endothelial and Kupffer cell killing. J Gastroenterol Hepatol 1995, 10(Suppl 1):S65-S67.
137. Sarphie T.G., D'Souza N.B., Deaciuc I.V. Kupffer cell inactivation prevents lipopolysaccharide-induced structural changes in the rat liver sinusoid: an electron-microscopic study. Hepatology 1996, 23:788-796.
138. Jaeschke H., Smith C.W., Clemens M.G., Ganey P.E., Roth R.A. Mechanisms of inflammatory liver injury: adhesion molecules and cytotoxicity of neutrophils. Toxicol Appl Pharmacol 1996, 139:213-226.
139. Leidal K.G., Munson K.L., Denning G.M. Small molecular weight secretory factors from Pseudomonas aeruginosa have opposite effects on IL-8 and RANTES expression by human airway epithelial cells. Am J Respir Cell Mol Biol 2001, 25:186-195.
140. Rose S., Baumann H., Jahreis G.P., Sayeed M.M. Diltiazem and superoxide dismutase modulate hepatic acute phase response in Gram-negative sepsis. Shock 1994, 1:87-93.
141. Pedersen P.V., Warner B.W., Bjornson H.S., Hiyama D.T., Li S., Rigel D.F., et al. Hemodynamic and metabolic alterations during experimental sepsis in young and adult rats. Surg Gynecol Obstet 1989, 168:148-156.
142. Spitzer J.J., Bagby G.J., Meszaros K., Lang C.H. Alterations in lipid and carbohydrate metabolism in sepsis. JPEN J Parenter Enteral Nutr 1988, 12(6 Suppl):53S-58S.
143. Spitzer J.J., Bagby G.J., Hargrove D.M., Lang C.H., Meszaros K. Alterations in the metabolic control of carbohydrates in sepsis. Prog Clin Biol Res 1989, 308:545-561.
144. Bannerman D.D., Goldblum S.E. Direct effects of endotoxin on the endothelium: barrier function and injury. Lab Invest 1999, 79:1181-1199.
145. Spolarics Z. Endotoxin stimulates gene expression of ROS-eliminating pathways in rat hepatic endothelial and Kupffer cells. Am J Physiol 1996, 270:G660-G666.
146. Liu P., McGuire G.M., Fisher M.A., Farhood A., Smith C.W., Jaeschke H. Activation of Kupffer cells and neutrophils for reactive oxygen formation is responsible for endotoxin-enhanced liver injury after hepatic ischemia. Shock 1995, 3:56-62.
147. Landau B.R., Hastings A.B., Zottu S. Pyocyanin and metabolic pathways in liver slices in vitro. Biochim Biophys Acta 1963, 74:629-634.
148. Stewart-Tull D.E., Armstrong A.V. The effect of 1-hydroxyphenazine and pyocyanin from Pseudomonas aeruginosa on mammalian cell respiration. J Med Microbiol 1972, 5:67-73.
149. Hassett D.J., Charniga L., Bean K., Ohman D.E., Cohen M.S. Response of Pseudomonas aeruginosa to pyocyanin: mechanisms of resistance, antioxidant defenses, and demonstration of a manganese-cofactored superoxide dismutase. Infect Immun 1992, 60:328-336.
150. Mahajan-Miklos S., Tan M.W., Rahme L.G., Ausubel F.M. Molecular mechanisms of bacterial virulence elucidated using a Pseudomonas aeruginosa-Caenorhabditis elegans pathogenesis model. Cell 1999, 96:47-56.
151. Muller M., Sorrell T.C. Oxidative stress and the mobilisation of arachidonic acid in stimulated human platelets: role of hydroxyl radical. Prostaglandins 1997, 54:493-509.
152. Ran H., Hassett D.J., Lau G.W. Human targets of Pseudomonas aeruginosa pyocyanin. Proc Natl Acad Sci U S A 2003, 100:14315-14320.
153. Scholl R.A., Lang C.H., Bagby G.J. Hypertriglyceridemia and its relation to tissue lipoprotein lipase activity in endotoxemic. Escherichia coli bacteremic, and polymicrobial septic rats. J Surg Res 1984, 37:394-401.
154. Harris H.W., Gosnell J.E., Kumwenda Z.L. The lipemia of sepsis: triglyceride-rich lipoproteins as agents of innate immunity. J Endotoxin Res 2000, 6:421-430.
155. Tiao G., Noguchi Y., Lieberman M.A., Fischer J.E., Hasselgren P.O. Sepsis stimulates polyamine biosynthesis in the liver and increases tissue levels of ornithine decarboxylase mRNA. Shock 1995, 4:403-410.
156. Munford R.S., Dietschy J.M. Effects of specific antibodies, hormones, and lipoproteins on bacterial lipopolysaccharides injected into the rat. J Infect Dis 1985, 152:177-184.
157. Munford R.S., Hall C.L., Dietschy J.M. Binding of Salmonella typhimurium lipopolysaccharides to rat high-density lipoproteins. Infect Immun 1981, 34:835-843.
158. Kitano H., Fukui H., Okamoto Y., Kikuchi E., Matsumoto M., Kikukawa M., et al. Role of albumin and high-density lipoprotein as endotoxin-binding proteins in rats with acute and chronic alcohol loading. Alcohol Clin Exp Res 1996, 20(1 Suppl):73A-76A.
159. Kitano H., Fukui H., Okamoto Y., Kikuchi E., Matsumoto M., Kikukawa M., et al. Protective mechanism of high-density lipoprotein against endotoxemia in chronic alcohol ingestion. Alcohol Clin Exp Res 1996, 20(9 Suppl):356A-359A.
160. Kumwenda Z.L., Wong C.B., Johnson J.A., Gosnell J.E., Welch W.J., Harris H.W. Chylomicron-bound endotoxin selectively inhibits NF-kappaB activation in rat hepatocytes. Shock 2002, 18:182-188.
161. Read T.E., Grunfeld C., Kumwenda Z.L., Calhoun M.C., Kane J.P., Feingold K.R., Rapp J.H. Triglyceride-rich lipoproteins prevent septic death in rats. J Exp Med 1995, 182:267-272.
162. Sun X., Kimura T., Kobayashi T., Noriki S., Imamura Y., Fukuda M., Yamaguchi A. Viability of liver grafts from fasted donor rats: relationship to sinusoidal endothelial cell apoptosis. J Hepatobiliary Pancreat Surg 2001, 8:268-273.
163. Shimizu H., Miyazaki M., Ito H., Nakagawa K., Ambiru S., Kato A., et al. Mechanism of cold ischemia-reperfusion-induced graft injury after orthotopic liver transplantation in rats. Hepatogastroenterology 2001, 48:216-219.
164. Fraser R., Day W.A., Fernando N.S. Atherosclerosis and the liver sieve. Cells of the Hepatic Sinusoid 1986, Vol. 1:317-322. The Kupffer Cell Foundation, Rijswijk.
165. Deleve L.D. Hepatic microvasculature in liver injury. Semin Liver Dis 2007, 27:390-400.
166. Deaciuc I.V., Spitzer J.A. Calcium content in liver and heart and its intracellular distribution in liver during endotoxicosis and sepsis in rats. Cell Calcium 1987, 8:365-376.
167. Sayeed M.M., Maitra S.R. Effect of diltiazem on altered cellular calcium regulation during endotoxic shock. Am J Physiol 1987, 253:R549-R554.
168. Mustafa S.B., Olson M.S. Effects of calcium channel antagonists on LPS-induced hepatic iNOS expression. Am J Physiol 1999, 277:G351-G360.
169. Liu P., Fisher M.A., Farhood A., Smith C.W., Jaeschke H. Beneficial effects of extracellular glutathione against endotoxin-induced liver injury during ischemia and reperfusion. Circ Shock 1994, 43:64-70.
170. Wojnar M.M., Hawkins W.G., Lang C.H. Nutritional support of the septic patient. Crit Care Clin 1995, 11:717-733.
171. ++-ATPase in the relaxation and contraction of hepatic sinusoidal endothelial fenestrae-effects of prostaglandin E1 and endothelin 1. Cells of the Hepatic Sinusoid 1997, vol. 6:313-317. Kupffer Cell Foundation, Leiden.
172. Watanabe N., Takashimizu S., Nishizaki Y., Kojima S., Kagawa T., Matsuzaki S. An endothelin A receptor antagonist induces dilatation of sinusoidal endothelial fenestrae: implications for endothelin-1 in hepatic microcirculation. J Gastroenterol 2007, 42:775-782.
173. Fraser R., Clark S.A., Bowler L.M., Murray F.E.M., Wakasugi J., Ishihara M., Tomikawa M. The opposite effects of nicotine and pantethine on the porosity of the liver sieve and lipoprotein metabolism. Cells of the Hepatic Sinusoid 1989, vol. 2:335-338. Kupffer Cell Foundation, Leiden.
174. Doria C., Marino I.R. Bacteremia using the molecular adsorbent recirculating system in patients bridged to liver transplantation. Exp Clin Transplant 2005, 3:289-292.
175. Ma Y.K., Yan L.N., Li B., Lu S.C., Huang A.H., Wen T.F., et al. Diagnosis and treatment of bacterial pneumonia in liver transplantation recipients: report of 33 cases. Chin Med J (Engl) 2005, 118:1879-1885.
176. Aduen J.F., Hellinger W.C., Kramer D.J., Stapelfeldt W.H., Bonatti H., Crook J.E., et al. Spectrum of pneumonia in the current era of liver transplantation and its effect on survival. Mayo Clin Proc 2005, 80:1303-1306.
177. Singh N., Gayowski T., Rihs J.D., Wagener M.M., Marino I.R. Evolving trends in multiple-antibiotic-resistant bacteria in liver transplant recipients: a longitudinal study of antimicrobial susceptibility patterns. Liver Transpl 2001, 7:22-26.
178. Singh N., Gayowski T., Wagener M.M., Marino I.R. Pulmonary infiltrates in liver transplant recipients in the intensive care unit. Transplantation 1999, 67:1138-1144.
179. Couetil J.P., Houssin D.P., Soubrane O., Chevalier P.G., Dousset B.E., Loulmet D., et al. Combined lung and liver transplantation in patients with cystic fibrosis. A 4 1/2-year experience. J Thorac Cardiovasc Surg 1995, 110:1415-1422. discussion 22-3.
180. Wade J., Rolando N., Williams R. The significance of aerobic Gram-negative bacilli in clinical specimens following orthotopic liver transplantation. Liver Transpl Surg 1998, 4:51-57.
181. Moreno A., Mensa J., Almela M., Vilardell J., Navasa M., Claramonte J., et al. [138 episodes of bacteremia or fungemia in patients with solid organ (renal or hepatic) transplantation]. Med Clin (Barc) 1994, 103:161-164.
182. Cuervas-Mons V., Julio Martinez A., Dekker A., Starzl T.E., Van Thiel D.H. Adult liver transplantation: an analysis of the early causes of death in 40 consecutive cases. Hepatology 1986, 6:495-501.
183. Spector I., Braet F., Shochet N.R., Bubb M.R. New anti-actin drugs in the study of the organization and function of the actin cytoskeleton. Microsc Res Tech 1999, 47:18-37.
184. Braet F., De Zanger R., Jans D., Spector I., Wisse E. Microfilament-disrupting agent latrunculin A induces an increased number of fenestrae in rat liver sinusoidal endothelial cells: comparison with cytochalasin B. Hepatology 1996, 24:627-635.
185. Braet F., Spector I., De Zanger R., Wisse E. A novel structure involved in the formation of liver endothelial cell fenestrae revealed by using the actin inhibitor misakinolide. Proc Natl Acad Sci U S A 1998, 95:13635-13640.
186. Braet F., Spector I., Shochet N., Crews P., Higa T., Menu E., et al. The new anti-actin agent dihydrohalichondramide reveals fenestrae-forming centers in hepatic endothelial cells. BMC Cell Biol 2002, 3:7.
187. Le Couteur D.G., Warren A., Cogger V.C., Smedsrod B., Sorensen K.K., De Cabo R., et al. Old age and the hepatic sinusoid. Anat Rec (Hoboken) 2008, 291:672-683.